T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.47B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.73B |
| 3 |
Tesla
TSLA
|
+$1.7B |
| 4 |
Northrop Grumman
NOC
|
+$1.67B |
| 5 |
Dollar Tree
DLTR
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.29B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.85B |
| 3 |
Texas Instruments
TXN
|
+$1.82B |
| 4 |
Microsoft
MSFT
|
+$1.27B |
| 5 |
Booking.com
BKNG
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.76% |
| 2 | Technology | 16.79% |
| 3 | Consumer Discretionary | 15.26% |
| 4 | Financials | 14.49% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Primoris Services
PRIM
$4.39B
| $342K | ﹤0.01% |
13,789
-42
| -0.3% | -$1.1K |
|
2302
Alaunos Therapeutics
TCRT
$4.88M
| $341K | ﹤0.01% |
710
+194
| +38% | +$83.2K |
|
|
KE
2303
Kimball Electronics
KE
$615M
| $340K | ﹤0.01% |
17,328
-3,020
| -15% | -$59.4K |
|
|
PRGX
2304
DELISTED
PRGX Global, Inc.
PRGX
| $340K | ﹤0.01% |
39,054
-285
| -0.7% | -$2.64K |
|
|
TSC
2305
DELISTED
TriState Capital Holdings, Inc.
TSC
| $338K | ﹤0.01% |
12,247
+1,548
| +14% | +$44.2K |
|
2306
LGI Homes
LGIH
$1.36B
| $337K | ﹤0.01% |
7,113
-191
| -3% | -$10.5K |
|
2307
National CineMedia
NCMI
$245M
| $337K | ﹤0.01% |
3,181
-75
| -2% | -$6.66K |
|
2308
KLX Energy Services
KLXE
$36.2M
| $336K | ﹤0.01% |
+2,102
| New | +$316K |
|
|
TBI
2309
Trueblue
TBI
$303M
| $335K | ﹤0.01% |
12,877
+246
| +2% | +$6.83K |
|
|
INN
2310
Summit Hotel Properties
INN
$651M
| $334K | ﹤0.01% |
24,696
+1,132
| +5% | +$15.6K |
|
|
ADMS
2311
DELISTED
Adamas Pharmaceuticals
ADMS
| $334K | ﹤0.01% |
16,661
+129
| +0.8% | +$3.03K |
|
2312
New Oriental
EDU
$8.32B
| $333K | ﹤0.01% |
4,500
-579,850
| -99% | -$48.1M |
|
2313
Peoples Bancorp
PEBO
$1.48B
| $333K | ﹤0.01% |
9,495
| – | – |
|
|
STBZ
2314
DELISTED
State Bank Financial Corporation. Common Stock
STBZ
| $333K | ﹤0.01% |
11,035
+226
| +2% | +$7.31K |
|
2315
DXP Enterprises
DXPE
$3.02B
| $332K | ﹤0.01% |
8,287
+96
| +1% | +$4.18K |
|
2316
Lands' End
LE
$389M
| $332K | ﹤0.01% |
18,895
-5,845
| -24% | -$138K |
|
2317
Skywest
SKYW
$4.2B
| $331K | ﹤0.01% |
5,627
+202
| +4% | +$12K |
|
2318
M/I Homes
MHO
$3.87B
| $330K | ﹤0.01% |
13,786
-136
| -1% | -$3.53K |
|
2319
Hurco Companies Inc
HURC
$143M
| $328K | ﹤0.01% |
7,273
-56
| -0.8% | -$2.46K |
|
2320
Verastem
VSTM
$614M
| $328K | ﹤0.01% |
3,768
+1,102
| +41% | +$110K |
|
|
KA
2321
DELISTED
Kineta, Inc. Common Stock
KA
| $326K | ﹤0.01% |
966
+1
| +0.1% | +$357 |
|
|
GHL
2322
DELISTED
Greenhill & Co., Inc.
GHL
| $326K | ﹤0.01% |
12,375
-391
| -3% | -$11.6K |
|
|
INFI
2323
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $326K | ﹤0.01% |
120,206
| – | – |
|
|
MOBL
2324
DELISTED
MobileIron, Inc.
MOBL
| $326K | ﹤0.01% |
61,430
+417
| +0.7% | +$2.08K |
|
2325
Agilysys
AGYS
$3.06B
| $325K | ﹤0.01% |
19,934
-307
| -2% | -$4.93K |
|
Similar funds
T. Rowe Price Associates's Q3 2018 Portfolio in Review
As of Q3 2018, T. Rowe Price Associates held 2,658 positions worth $685B, up 4.7% from $654B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q3 2018 filing shows 77 new, 1,268 increased, 1,098 reduced and 77 closed positions. Its largest new stake was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M. The largest sale was Broadcom, an estimated $3.29B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2018 buy was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M.
- T. Rowe Price Associates added most to NVIDIA in Q3 2018, an estimated $2.47B increase.
- T. Rowe Price Associates's biggest Q3 2018 reduction was Broadcom, cutting an estimated $3.29B.
- T. Rowe Price Associates fully exited DCT Industrial Trust Inc. in Q3 2018, selling an estimated $345M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $685B portfolio in Q3 2018.
- T. Rowe Price Associates opened 77 new positions and closed 77 in Q3 2018.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $685B.
Based on T. Rowe Price Associates's 13F filing for Q3 2018, filed 14 Nov 2018.